Evolutionary and Comparative Genomics to Drive Rational Drug Design, with Particular Focus on Neuropeptide Seven-Transmembrane Receptors.

Michael Furlong, Jae Young Seong
Author Information
  1. Michael Furlong: Graduate School of Biomedical Sciences, Korea University, Seoul 02841, Republic of Korea.
  2. Jae Young Seong: Graduate School of Biomedical Sciences, Korea University, Seoul 02841, Republic of Korea.

Abstract

Seven transmembrane receptors (7TMRs), also known as G protein-coupled receptors, are popular targets of drug development, particularly 7TMR systems that are activated by peptide ligands. Although many pharmaceutical drugs have been discovered via conventional bulk analysis techniques the increasing availability of structural and evolutionary data are facilitating change to rational, targeted drug design. This article discusses the appeal of neuropeptide-7TMR systems as drug targets and provides an overview of concepts in the evolution of vertebrate genomes and gene families. Subsequently, methods that use evolutionary concepts and comparative analysis techniques to aid in gene discovery, gene function identification, and novel drug design are provided along with case study examples.

Keywords

References

Mol Pharmacol. 2003 Jun;63(6):1256-72 [PMID: 12761335]
ACS Chem Neurosci. 2015 Apr 15;6(4):681-92 [PMID: 25660762]
Nat Genet. 2002 May;31(1):100-5 [PMID: 11967531]
Bioessays. 2005 Sep;27(9):937-45 [PMID: 16108068]
Prog Neurobiol. 2006 Sep;80(1):1-19 [PMID: 17070981]
Gen Comp Endocrinol. 2011 Jan 1;170(1):68-78 [PMID: 21036176]
PLoS One. 2014 Feb 03;9(2):e87901 [PMID: 24498396]
Genetics. 2005 Feb;169(2):1157-64 [PMID: 15654095]
Genome Res. 2003 Jun;13(6A):1111-22 [PMID: 12799348]
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1642-7 [PMID: 19164555]
J Chem Neuroanat. 2009 Mar;37(2):105-11 [PMID: 19124073]
Neuropeptides. 2004 Aug;38(4):141-51 [PMID: 15337367]
Dev Suppl. 1994;:125-33 [PMID: 7579513]
Chromosome Res. 2008;16(1):171-81 [PMID: 18293111]
Genetics. 2011 Aug;188(4):799-808 [PMID: 21828280]
Curr Opin Chem Biol. 1998 Feb;2(1):31-9 [PMID: 9667917]
J Struct Funct Genomics. 2003;3(1-4):75-84 [PMID: 12836687]
Genomics. 2005 Jun;85(6):688-703 [PMID: 15885496]
Genome Res. 2002 Dec;12(12):1910-20 [PMID: 12466295]
Mol Cells. 2010 Aug;30(2):149-54 [PMID: 20799012]
Gen Comp Endocrinol. 2007 Aug-Sep;153(1-3):98-107 [PMID: 17286976]
Genome Res. 2007 Sep;17(9):1254-65 [PMID: 17652425]
Peptides. 2007 Apr;28(4):798-805 [PMID: 17306418]
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3622-7 [PMID: 20139301]
Mamm Genome. 2016 Aug;27(7-8):259-78 [PMID: 27364349]
Genome Res. 2007 Mar;17(3):320-7 [PMID: 17284679]
Pharmacol Ther. 2006 Jun;110(3):525-32 [PMID: 16289308]
Mol Biol Evol. 2003 Aug;20(8):1290-8 [PMID: 12777526]
Mol Biol Evol. 2013 May;30(5):1119-30 [PMID: 23427277]
Cytogenet Genome Res. 2013;141(2-3):80-9 [PMID: 23949002]
Behav Brain Res. 2016 Nov 1;314:125-33 [PMID: 27498247]
Front Endocrinol (Lausanne). 2014 Jun 19;5:93 [PMID: 24994999]
Front Neurosci. 2013 Apr 10;7:28 [PMID: 23596380]
Nature. 1999 Nov 25;402(6760):411-3 [PMID: 10586880]
Gastroenterology. 2007 May;132(6):2131-57 [PMID: 17498508]
Genomics. 1993 Apr;16(1):1-19 [PMID: 8486346]
Front Neurosci. 2014 Aug 15;8:255 [PMID: 25177268]
Dev Biol. 2012 Aug 1;368(1):44-53 [PMID: 22641013]
Endocrinol Metab (Seoul). 2014 Sep;29(3):320-7 [PMID: 25309791]
J Biol Chem. 2015 Feb 27;290(9):5696-706 [PMID: 25561730]
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16044-9 [PMID: 24043829]
Mol Biol Evol. 2011 Sep;28(9):2471-80 [PMID: 21402729]
Genetics. 2001 Dec;159(4):1789-804 [PMID: 11779815]
PLoS One. 2013 Jun 11;8(6):e65420 [PMID: 23776481]
J Virol. 2014 Jul;88(14):7915-28 [PMID: 24789792]
Front Neurosci. 2012 Jan 24;6:3 [PMID: 22291614]
BMC Evol Biol. 2010 May 06;10:135 [PMID: 20459630]
Nature. 2008 Jun 19;453(7198):1064-71 [PMID: 18563158]
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4332-41 [PMID: 25267646]
J Mol Endocrinol. 2014 Jun;52(3):T15-27 [PMID: 24598200]
Gen Comp Endocrinol. 2014 Jan 1;195:107-15 [PMID: 24188887]
Front Endocrinol (Lausanne). 2014 Apr 04;5:41 [PMID: 24772105]
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):E3526-34 [PMID: 23980168]
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12127-32 [PMID: 19564597]
Proc Natl Acad Sci U S A. 2013 May 28;110(22):E2028-37 [PMID: 23671109]
EMBO J. 2006 Jul 12;25(13):3012-23 [PMID: 16778767]
Nat Rev Drug Discov. 2008 Apr;7(4):339-57 [PMID: 18382464]
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17489-94 [PMID: 16287967]
Pharmacol Rev. 2013 May 17;65(3):967-86 [PMID: 23686350]
Endocrinology. 2014 May;155(5):1864-73 [PMID: 24517231]
BMC Evol Biol. 2005 Apr 14;5:28 [PMID: 15831095]
PLoS Comput Biol. 2009 Jan;5(1):e1000252 [PMID: 19119408]
Endocrinology. 2009 Jun;150(6):2837-46 [PMID: 19164475]
Int Rev Cytol. 2006;252:163-218 [PMID: 16984818]
PLoS Biol. 2005 Oct;3(10):e314 [PMID: 16128622]
Nat Rev Drug Discov. 2011 Aug 01;10(8):579-90 [PMID: 21804595]
Genome Biol Evol. 2014 Sep 19;6(10):2681-96 [PMID: 25240057]
Br J Pharmacol. 2015 Jul;172(13):3212-28 [PMID: 25231237]
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17409-14 [PMID: 24101476]
Trends Pharmacol Sci. 2012 Jan;33(1):17-27 [PMID: 22032986]
Genome Biol Evol. 2011;3:687-701 [PMID: 21705473]
Mol Biol Evol. 2015 Nov;32(11):2803-17 [PMID: 26337547]
J Biol Chem. 2015 Nov 6;290(45):27021-39 [PMID: 26363071]
PLoS One. 2012;7(3):e32923 [PMID: 22470432]
FEBS J. 2010 Dec;277(24):5006-13 [PMID: 21126314]
Nature. 2014 Jan 9;505(7482):174-9 [PMID: 24402279]
Am J Physiol Endocrinol Metab. 2013 Aug 1;305(3):E348-66 [PMID: 23715729]
Sci Rep. 2016 Feb 24;6:21453 [PMID: 26907960]
Regul Pept. 2000 Nov 24;95(1-3):25-34 [PMID: 11062329]

Word Cloud

Similar Articles

Cited By